Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01081353 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin
A Phase 1 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01081353: Completed Phase 1 study, sponsored by Bayer.
NCT01081353 is a Phase 1 study that has completed, run by Bayer. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01081353, a Phase 1 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
To determine the bioequivalence of new formula of aspirin relative to the established commercial effervescent aspirin when taken orally by healthy adult subjects
Interventions
- DRUG Acetylsalicylic Acid (Aspirin BAY1019036)
- DRUG Alka Seltzer Extra Strength
- DRUG Aspirin Migraine
- DRUG Aspirin Aspro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
What the finished NCT01081353 record still lists
NCT01081353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 4 interventions - of which Acetylsalicylic Acid (Aspirin BAY1019036) is the first listed.
NCT01081353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01081353 about?
NCT01081353 is a clinical study titled "Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin". To determine the bioequivalence of new formula of aspirin relative to the established commercial effervescent aspirin when taken orally by healthy adult subjects
What is the current status of trial NCT01081353?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2010-02. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01081353?
The interventions under investigation include: Acetylsalicylic Acid (Aspirin BAY1019036) (DRUG), Alka Seltzer Extra Strength (DRUG), Aspirin Migraine (DRUG), Aspirin Aspro (DRUG).
Who is sponsoring clinical trial NCT01081353?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01081353's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia